Why Startups Fail Before They Launch

Failure looks like an event.

A product ships, nobody comes, the runway ends, and someone writes a post-mortem about timing.

It rarely happens that way.

By launch day, the outcome is usually already being determined. The company is executing decisions made months earlier, when there were few customers, little evidence and plenty of conviction.

Launch is not when a startup fails. It is when the failure becomes visible to everyone else.

The underlying mistake is almost always the same: an assumption becomes a commitment before the evidence justifies it.

Commit to a market before proving demand. Commit to a problem before establishing urgency. Commit to a product before proving the solution. Commit to distribution before proving acquisition. Commit to a team before proving the business.

The earlier the commitment, the more expensive it becomes to discover you were wrong.

Six commitments do most of the damage.

Commitment 01

Committing to a market before knowing anyone wants it

CB Insights analysed 431 VC-backed companies that shut down after 2023, identifying causes for 385 of them.¹ Running out of capital tops the list at 70%. But the causes underneath it are more useful: poor product-market fit at 43%, bad timing at 29%, and unsustainable unit economics at 19%.

Capital is where these stories end. It is not where they go wrong.

And this is not just a seed-stage problem. Twenty Series B+ companies in the sample still cited product-market fit as a cause of failure. They had raised on early traction that never widened into anything larger.

Validation is not a seed-stage chore you complete and move past. It is a question that can stay unanswered through several rounds of funding.

And it can usually be investigated before the product exists.

Founders skip that investigation for a simple reason. Building feels like progress and asking does not. Code compiles, designs render, a prototype gives the team something to show investors on Friday. A sceptical customer gives you a list of reasons the idea might be wrong.

So the work that could save the company gets deferred in favour of the work that feels like momentum.

Steve Blank’s instruction has not improved with age because it did not need to: get out of the building.² The objective is not to prove the idea right. It is to find out how it could be wrong while being wrong is still cheap.

Commitment 02

Committing to a problem before establishing urgency

This one is more dangerous because it can survive validation.

Founders run their interviews. Everyone is polite. Everyone agrees the problem is annoying. The team hears twenty yeses and starts building.

Eighteen months later, nobody will pay.

The failure is not necessarily that the interviews were bad. It is that a problem people recognise is not the same as a problem they urgently need solved.

Economists have been measuring this gap for decades. Research comparing stated preference — what people say they would pay in a hypothetical scenario — with revealed preference — what they actually pay — consistently finds that the hypothetical figure overstates the real one, often substantially.³

The bias is structural rather than dishonest. Saying yes in an interview costs nothing. Signing a purchase order costs money, political capital and the risk of being wrong in front of colleagues.

So the questions are not “would you use this?” or even “is this a problem?”

They are: what are you doing about it today, what does that cost you, what happens if you do nothing, who owns the budget, and what have you already tried?

A customer with no solution may have a serious problem. A customer facing little consequence from inaction does not have an urgent problem.

The most common version of this failure is horizontal. A team validates a problem across four industries, finds it real in all of them, and reads breadth as strength.

But a problem spread thinly is urgent nowhere in particular.

Real everywhere and urgent nowhere kills companies just as reliably as having no problem at all.

It is harder to spot because the validation data looks like success.

Commitment 03

Committing to a product before proving the solution

Once building starts, something changes quietly.

The question stops being “does anyone want this?” and becomes “is this good?”

The second question is easier and more pleasant. It has clear answers, rewards craft, and can absorb an entire team for a year while the first question goes unasked.

The tell is the roadmap.

When a team that has not yet proven demand is debating the fourth feature, it has stopped testing a hypothesis and started decorating one.

Startup Genome’s study of more than 3,200 high-growth technology startups found that around 70% had scaled prematurely along at least one dimension, including adding nice-to-have features, overhiring and overspending.⁴ The useful insight is the classification: building beyond what your evidence supports is scaling, whatever the headcount says.

Every feature is a small commitment. Every sprint spent polishing something unproven makes it harder to kill. The product gets better while the business case stays exactly as uncertain as it was before.

A startup should earn complexity.

Until the evidence supports it, the product should be embarrassingly small.

Commitment 04

Committing to distribution after the product

Most founders can describe their product in detail and their route to customers in a sentence.

Usually the sentence contains the words “content”, “partnerships” or “word of mouth”.

Distribution gets treated as something that happens once the product is ready.

It isn’t.

A product without a repeatable path to a buyer is not yet a business. It is an artefact that may become one.

Thiel put it bluntly in Zero to One: “poor sales rather than bad product is the most common cause of failure.”⁵

The question is not whether you can acquire one customer. It is whether you can explain how you acquire the next hundred.

Can you reach the buyer? Does that buyer have authority to purchase? How long does the sale take? What does acquisition cost? Does that number sit comfortably below what the customer is worth?

These are not post-launch questions. They are build-phase questions.

If the product is ready before you know how it gets bought, you have solved half the problem and assumed the rest.

Commitment 05

Committing to a team before proving the business

Hiring feels like progress.

A team of ten looks more real than a founder and two contractors. Departments appear, titles appear, meetings appear, and the company starts to resemble the company you imagined.

The problem is that payroll converts uncertainty into fixed cost.

The CB Insights shutdown data makes the point. The 431 companies raised $17.5bn between them, with a median of $11m. Around 15% died with more than 100 employees, and two-thirds were already shrinking headcount in the six months before the end.

Scale did not save them. In most cases it arrived first and left first.

The mechanics are unforgiving. Every hire reduces the time you have to discover the thesis is wrong. Every hire adds coordination overhead. And every hire narrows the pivot: a small team changes direction in a week, while a large team needs an explanation, a reorganisation and sometimes a new strategy deck.

Worse, hiring becomes a substitute for evidence.

“We need a sales team.”
“We need a VP Engineering.”
“We need five more developers.”

Maybe. But the more useful question is:

What evidence exists that this problem requires more people rather than more learning?

Headcount should follow evidence, not create the appearance of it.

Commitment 06

Committing before you have the right to

The first five are process failures. This one sits underneath them.

Founder-market fit is usually described as passion. It should not be.

Passion is cheap and available to anyone. The valuable thing is specific, hard-earned insight into a specific market: years inside an industry, a network that returns calls, a real understanding of why the obvious solutions have failed.

The research is more precise than the folklore. A study of 338 high-technology ventures found that founders’ industry-specific experience raised venture sales, while generic human capital — education, unrelated work history — did not.⁶ An analysis of more than 2,000 founders in the Kauffman Firm Survey found something sharper: prior industry experience improved the accuracy of founders’ own revenue forecasts, but prior startup experience did not.⁷

That inverts a common assumption. Having founded a company before does not appear to help you predict how the next one will perform. Knowing the industry does.

A founder with genuine market experience may not have the answers, but they know where to look. They know who has the problem, what people do today, who signs the cheque, and why previous attempts failed.

But the advantage has a shelf life.

The mental models that gave a founder an edge at month three can become the assumptions they cannot see past at year three.

Founder-market fit is an advantage, not an exemption from being wrong.

Weak founder-market fit removes the judgement that would have caught the other five failures.

Strong founder-market fit, left unchallenged, quietly becomes the sixth.

How a venture studio changes the odds

A studio does not eliminate these risks.

It changes when they surface, what they cost, and how difficult they are to reverse.

The advantage is not better ideas. It is the ability to keep commitments small until the evidence makes them worth enlarging.

We separate the decision to build from the desire to build. Every venture starts with explicit hypotheses and pre-agreed kill criteria. The point is to decide what would falsify an idea before anyone is emotionally invested.

Our gates are therefore decisions, not updates. A review that cannot end in a no is theatre. Ours can, and sometimes does.

We test intent against behaviour. Discovery interviews establish that a problem exists. Letters of intent, pre-payments, pilot commitments and paid trials establish that it matters. We look for the second before we build for the first.

We keep the team light until the evidence earns weight. Ventures draw on shared product, design, engineering and legal capability rather than hiring against an unproven thesis. A venture earns a permanent team when the business needs one, not because a permanent team makes it feel more real.

We validate distribution alongside the product. Route to market, buyer authority, sales cycle and acquisition economics are build-phase questions. Discovering after launch that the product works but the economics do not is an expensive way to learn arithmetic.

We pair domain conviction with outside challenge. Founder-market fit is the one input a studio cannot manufacture, so we select for it — and then make sure the founder is not the only person in the room. Deep industry experience is an advantage and an assumption set at the same time. A studio’s job is to keep asking the questions the expert has stopped asking.

We run the pattern repeatedly. A founder meets these failures once, at maximum cost, with no comparison set. A studio meets them across a portfolio. That does not make us smarter. It makes the shapes easier to recognise, and a pattern recognised early can be stopped early.

The limits are worth stating plainly. A studio can supply process, capital and capability. It cannot manufacture market demand, and it cannot guarantee timing.

So the goal is not to make every venture succeed.

It is to make sure commitment follows evidence.

An idea should not become a company because the team is excited. A prototype should not become a product because it works. A product should not become a business because it has users. And a company should not become a permanent organisation because there is money left in the bank.

Each step should be earned by the evidence from the step before it.

The best venture-building process does not eliminate uncertainty. It makes sure you never spend millions proving what you could have learned for thousands.

Notes

1. CB Insights, “The top 9 reasons startups fail”, March 2026. cbinsights.com ↩
2. Steve Blank, The Four Steps to the Epiphany, 2005. ↩
3. For an overview of the gap between hypothetical and actual willingness to pay, see the meta-analytic literature on contingent valuation, summarised in John Loomis, “What’s to Know About Hypothetical Bias in Stated Preference Valuation Studies?”, Journal of Economic Surveys, 2011. ↩
4. Startup Genome, “Premature Scaling: A Deep Dive”. startupgenome.com ↩
5. Peter Thiel, Zero to One, 2014. ↩
6. Colombo et al., “A close look at the contingencies of founders’ effect on venture performance”, Industrial and Corporate Change, vol. 29, issue 4, 2020. ↩
7. Study of entrepreneur forecast performance using the Kauffman Firm Survey (n = 2,304), Journal of Business Venturing, vol. 29, issue 1, 2014. ↩